Format

Send to

Choose Destination
Cancer Cell. 2006 Jan;9(1):13-22.

Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis.

Author information

1
Molecular Oncology Research Institute and Department of Radiation Oncology, Tufts-New England Medical Center, 750 Washington Street #5609, Boston, Massachusetts 02111, USA.

Abstract

Cyclin D1 is a multifunctional protein that activates CDK4 and CDK6, titrates Cip/Kip CDK inhibitors to increase CDK2 activity, and modulates the function of certain transcription factors. To specifically test the importance of cyclin D1-associated kinase activity, we generated "knockin" mice expressing mutant cyclin D1 deficient in activating CDK4/6. The development of several cyclin D1-dependent compartments, including mammary glands, proceeds relatively normally in these animals, demonstrating that cyclin D1-associated kinase activity is largely dispensable for development of these tissues. Strikingly, knockin mice were resistant to breast cancers initiated by ErbB-2. These results demonstrate a differential requirement for cyclin D1-CDK4/6 kinase activity in development versus tumorigenesis and strongly support cyclin D1-dependent kinase activity as a specific therapeutic target in breast cancer.

PMID:
16413468
DOI:
10.1016/j.ccr.2005.12.019
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center